Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

BDB018

Small molecule · Agonist of Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8) · developed by Eikon Therapeutics

Phase 1 Most advanced trial (none active)
EIKN Developer
1 Registered trials

What is BDB018?

BDB018 is a TLR7 and TLR8 agonist that binds and activates these innate immune receptors, stimulating maturation of antigen-presenting cells such as dendritic cells. It is being studied in solid tumors.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Targets
Toll-like receptor 7 (TLR7), Toll-like receptor 8 (TLR8)
Mechanism
Agonist of Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8)
Pathways
TLR7/8-mediated innate immune signaling, dendritic cell maturation and activation, pro-inflammatory cytokine production, cytotoxic T-lymphocyte and B-lymphocyte responses
Therapy area
Oncology
Developer
Eikon Therapeutics (EIKN)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04840394 Phase 1 Tumor, Solid Completed EIKN

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Tumor, Solid

Other drugs acting on TLR7 / TLR8

Resiquimod Phase 2/3 Resiquimod Hydrogel-based Phase 1/2

More from Eikon Therapeutics

EIK1005 Phase 1/2 Resiquimod Phase 2/3

Sources

Updated Oct 11, 2026. Something wrong or missing? Report it on the EIKN page.

Follow EIKN, the company behind BDB018

See EIKN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

EIKN catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.